Kymera Therapeutics (KYMR)
Nasdaq • KYMR • US5015751044
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 14.5% of free float sold short, 11.6 days to cover, cost to borrow 0.53%. Sign up for live short interest data.
Market Cap
11.2b USD | # 1497 in US
Volume
840.3k shares | 97.85m USD
Shares Outstanding
85.37m
Free Float Shares
79.96% | 68.26m
